Table 1.
References | Title | Total Citations * | Total Citations per Year ** |
---|---|---|---|
Enels EA, 2011, JAMA [7] | Spectrum of cancer risk among US solid organ transplant recipients | 856 | 78 |
De Vuyst H, 2009, Int J Cancer [8] |
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis | 684 | 53 |
Machalek DA, 2012, Lancet Oncol [9] | Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis | 621 | 62 |
Palefsky JM, 2011, New Engl J Med [10] | HPV vaccine against anal HPV infection and anal intraepithelial neoplasia | 615 | 56 |
Ajani JA, 2008, JAMA [11] | Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial | 594 | 42 |
James RD, 2013, Lancet Oncol [12] | Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial | 395 | 44 |
Silverberg MJ, 2012, Clin Infect Dis [13] | Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America | 369 | 37 |
Kachnic LA, 2013, Int J Radiat Oncol Biol Phys [14] |
RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal | 351 | 39 |
Shiels MS, 2009, J Acquired Immune Defic Syndr [15] |
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals | 350 | 27 |
Giuliano AR, 2011, Lancet [16] | Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study | 335 | 31 |
* Number of times each document has been cited; ** yearly average number of times each document has been cited.